PortfoliosLab logoPortfoliosLab logo
CG vs. CVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CG vs. CVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Carlyle Group Inc. (CG) and CVS Health Corporation (CVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CG achieves a -21.53% return, which is significantly lower than CVS's 30.67% return. Over the past 10 years, CG has outperformed CVS with an annualized return of 16.61%, while CVS has yielded a comparatively lower 3.70% annualized return.


CG

1D
2.69%
1M
-6.25%
YTD
-21.53%
6M
-20.51%
1Y
-1.61%
3Y*
18.18%
5Y*
3.96%
10Y*
16.61%

CVS

1D
1.47%
1M
3.92%
YTD
30.67%
6M
30.57%
1Y
59.29%
3Y*
16.60%
5Y*
7.08%
10Y*
3.70%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CG vs. CVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CG
The Carlyle Group Inc.
-21.53%20.20%28.05%42.55%-43.78%78.46%1.62%116.75%-27.28%59.83%
CVS
CVS Health Corporation
30.67%84.35%-40.77%-12.53%-7.63%54.87%-5.14%17.26%-7.04%-5.75%

Correlation

The correlation between CG and CVS is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.19

Correlation (10Y)
Calculated over the trailing 10-year period

0.23

Correlation (All Time)
Calculated using the full available price history since May 3, 2012

0.24

The correlation between CG and CVS shifts across timeframes, from 0.07 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CG:

$16.43B

CVS:

$130.41B

EPS

CG:

$1.48

CVS:

$2.30

PE Ratio

CG:

30.90

CVS:

44.29

PS Ratio

CG:

4.23

CVS:

0.32

PB Ratio

CG:

2.23

CVS:

1.68

Total Revenue (TTM)

CG:

$3.99B

CVS:

$407.91B

Gross Profit (TTM)

CG:

$2.92B

CVS:

$56.59B

EBITDA (TTM)

CG:

$1.01B

CVS:

$9.99B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CG vs. CVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CG
CG Risk / Return Rank: 3939
Overall Rank
CG Sharpe Ratio Rank: 4141
Sharpe Ratio Rank
CG Sortino Ratio Rank: 3636
Sortino Ratio Rank
CG Omega Ratio Rank: 3636
Omega Ratio Rank
CG Calmar Ratio Rank: 4141
Calmar Ratio Rank
CG Martin Ratio Rank: 4141
Martin Ratio Rank

CVS
CVS Risk / Return Rank: 8686
Overall Rank
CVS Sharpe Ratio Rank: 8989
Sharpe Ratio Rank
CVS Sortino Ratio Rank: 8282
Sortino Ratio Rank
CVS Omega Ratio Rank: 8787
Omega Ratio Rank
CVS Calmar Ratio Rank: 8888
Calmar Ratio Rank
CVS Martin Ratio Rank: 8787
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CG vs. CVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Carlyle Group Inc. (CG) and CVS Health Corporation (CVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CGCVSDifference
Sharpe ratioReturn per unit of total volatility

-1.96

Sortino ratioReturn per unit of downside risk

-2.14

Omega ratioGain probability vs. loss probability

1.02

1.35

-0.33

Calmar ratioReturn relative to maximum drawdown

-0.04

3.62

-3.67

Martin ratioReturn relative to average drawdown

-0.08

9.33

-9.41

CG vs. CVS - Sharpe Ratio Comparison

The current CG Sharpe Ratio is -0.04, which is lower than the CVS Sharpe Ratio of 1.92. The chart below compares the historical Sharpe Ratios of CG and CVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CG vs. CVS - Drawdown Comparison

The maximum CG drawdown since its inception was -62.69%, roughly equal to the maximum CVS drawdown of -64.07%. Use the drawdown chart below to compare losses from any high point for CG and CVS.


Loading charts...

Drawdown Indicators


CGCVSDifference

Max Drawdown

Largest peak-to-trough decline

-62.69%

-64.07%

+1.38%

Max Drawdown (1Y)

Largest decline over 1 year

-37.83%

-16.44%

-21.39%

Max Drawdown (3Y)

Largest decline over 3 years

-38.53%

-43.98%

+5.45%

Max Drawdown (5Y)

Largest decline over 5 years

-56.75%

-56.79%

+0.04%

Max Drawdown (10Y)

Largest decline over 10 years

-56.75%

-56.79%

+0.04%

Current Drawdown

Current decline from peak

-32.67%

0.00%

-32.67%

Average Drawdown

Average peak-to-trough decline

-21.75%

-19.54%

-2.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

19.76%

6.38%

+13.38%

Volatility

CG vs. CVS - Volatility Comparison

The Carlyle Group Inc. (CG) has a higher volatility of 10.06% compared to CVS Health Corporation (CVS) at 7.50%. This indicates that CG's price experiences larger fluctuations and is considered to be riskier than CVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CGCVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.06%

7.50%

+2.56%

Volatility (6M)

Calculated over the trailing 6-month period

27.69%

25.88%

+1.81%

Volatility (1Y)

Calculated over the trailing 1-year period

36.18%

31.05%

+5.13%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

39.78%

29.98%

+9.80%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

37.38%

29.30%

+8.08%

Dividends

CG vs. CVS - Dividend Comparison

CG's dividend yield for the trailing twelve months is around 3.06%, more than CVS's 2.61% yield.


PositionTTM20252024202320222021202020192018201720162015
CG
The Carlyle Group Inc.
3.06%2.37%2.77%3.38%4.11%1.82%3.18%4.24%7.87%5.41%11.02%21.70%
CVS
CVS Health Corporation
2.61%3.35%5.93%3.06%2.36%1.94%2.93%2.69%3.05%2.76%2.15%1.43%

Financials

CG vs. CVS - Financials Comparison

This section allows you to compare key financial metrics between The Carlyle Group Inc. and CVS Health Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00B20222023202420252026
189.60M
100.43B
(CG) Total Revenue
(CVS) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CG and CVS have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CG has higher volatility (10.06%) compared to CVS (7.50%). In terms of maximum drawdown, CG dropped -62.69% vs CVS's -64.07%.

CVS currently has the higher Sharpe Ratio (1.92 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CG and CVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer